India not to fix a benchmark in selecting covid-19 vaccine

In the US, the drug regulator has set a key parameter of 50% efficacy for approving a vaccine.Amid vaccine hunt, India needs to assess the optimal level of immunization, said epidemiologists

from Livemint - News https://ift.tt/2FCKx7v
https://ift.tt/eA8V8J